EFH
AZN icon

Eaton Financial Holdings’s AstraZeneca AZN Stock Holding History

Eaton Financial Holdings’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,433
Closed -$1.41M – 76
2023
Q4 		$1.41M Hold
10,433
– – 0.34% 80
2023
Q3 		$1.41M Buy
+10,433
New +$1.42M 0.38% 74

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Eaton Financial Holdings's AZN Position: Q1 2024 in Review

Eaton Financial Holdings sold out of AstraZeneca (AZN) in Q1 2024, closing a stake of 10,433 shares — an estimated $1.41M sold.

Eaton Financial Holdings first reported a position in AZN in Q3 2023 and held it in 2 quarters. The position peaked at $1.41M in Q3 2023. 1,141 funds tracked by Wall St. Rank hold AZN as of Q1 2024.

  • Eaton Financial Holdings reported no remaining AstraZeneca position as of Q1 2024 after selling out during the quarter.
  • Eaton Financial Holdings sold 10,433 AstraZeneca shares in Q1 2024, an estimated $1.41M.
  • Eaton Financial Holdings first reported a position in AstraZeneca in Q3 2023 and held it in 2 quarters.
  • Eaton Financial Holdings's AstraZeneca position peaked at $1.41M in Q3 2023.
  • 1,141 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2024.

Based on Eaton Financial Holdings's 13F filing for Q1 2024, filed 19 Apr 2024.